This research presents immunohistochemical strategies for assessing the interactions at the immediate interface between micro-scale implanted devices and the surrounding brain tissue during inflammatory astrogliotic reactions. This includes preparation, microscopy and analysis techniques for obtaining images of the intimate contact between neural cells and the surface of implantable micro-electromechanical systems (MEMS) devices. The ability to visualize the intact interface between an implant and the surrounding tissue allows researchers to examine tissue that is unchanged from its native implanted state. Conversely, current popular techniques involve removing the implant. This tends to cause damage to the tissue immediately surrounding the implant and can hinder one's ability to differentiate inflammatory responses to the implant versus physical damage occurring from removal of the implant from the tissue. Due to advances in microscopy and staining techniques, it is now possible to visualize the intact tissue-implant interface. This paper presents the development of imaging techniques for visualizing the intact interface between neural tissue and implanted devices. This is particularly important for understanding both the acute and chronic neuroinflammatory responses to devices intended for long-term use in a prosthetic system. Non-functional, unbonded devices were imaged in vitro and in vivo at different times post-implantation via a range of techniques. Using these techniques, detailed interactions could be seen between delicate cellular processes and the electrode surface, which would have been destroyed using conventional histology processes.
Introduction
Advances in microelectrode technology have already had a significant impact on the field of neuroscience. The multitude of applications for microelectrodes includes: gaining a better understanding of the functions of individual neurons and complex neural networks [1] [2] [3] ; providing an interface between the central nervous system and prosthetics interacting with the environment [1] [2] [3] [4] [5] and treating various neurological disorders via drug delivery [6] . For many applications, devices for implantation into living tissue are required, and must maintain reliable physical and electrical characteristics over the long-term life of the implant. The medical and scientific impact of such an implant is the driving force behind much neural interface technology development. However, this goal is difficult to achieve due to the complex inflammatory response resulting from the implantation process. Various methods to reduce the natural inflammatory response are being attempted, but suffer from a lack of detailed information regarding the interaction between tissue and implant.
Vascular damage, ischemia, anoxia, necrosis due to implantation and the introduction of non-endogenous cells to the area around the implant are all factors that contribute to the initial inflammatory response [7] . This response will vary due to the particular material from which the implant is fabricated as well [8] . The end result of this response is the formation of a scar, or glial sheath, surrounding the implant that electrically isolates it from the neural tissue of interest [9, 10] . Formation of this sheath is termed gliosis and is most commonly characterized by reactive astrocytes [7, 9] . Understanding this interaction between implant and tissue is a crucial step in developing stable, long-term neural microelectrodes.
In an effort to characterize the neural inflammatory response to an implanted microelectrode, various histological techniques have been utilized. Many researchers have used hematoxalin and eosin (H&E) or Toluidine Blue staining to image tissue following implantation of a neural implant [10, 11] . Others have used immunohistochemical-staining techniques to visualize various proteins or cell types [12, 13] . Despite the wealth of information obtainable from these techniques, a critical component is often lost. Because most implanted electrodes cannot be sectioned using a cryostat or vibrating microtome (vibratome), the majority of studies have been performed on tissue after the probe has been removed. Even when electrodes fabricated from soft, sectionable materials are used, the difference in mechanical properties between probe and tissue leads to an unwanted dissociation. Staining the explanted electrode and the remaining tissue has shown that a significant amount of cellular material is removed along with the electrode [13] [14] [15] . For this reason, removing the probe from the tissue prior to sectioning and visualization is undesirable since much information about the materialtissue interface interaction is lost. Recently, Bragin et al have demonstrated that it is possible to capture an intact electrode within tissue sectioned using a vibratome [16] . This technique is rather difficult, and becomes even more cumbersome when sectioning the 10-60 µm slices required for standard imaging techniques. Thus, it is imperative that thick sections be used. Confocal laser scanning microscopy (CLSM) in conjunction with the novel fluorescent-staining techniques presented here will permit deep penetration into the tissue required for such analysis.
This paper presents novel in situ imaging techniques, combining fluorescent staining with advanced microscopy techniques, such as CLSM, to explore the structure of the intact tissue-implant interface. The ability to visualize the intact interface provides numerous benefits. The extent of the inflammation which causes device failure can be determined more readily if the tissue remains intact, as the exact interface is readily identifiable. Cell attachment to the electrode surface and changes in cellular morphology at the various stages of the inflammatory response can be seen. The effects that surface properties of the implants have on the inflammatory response can be studied much more efficiently if the tissue-implant interface is not destroyed in the imaging procedure. For these reasons, the long-term goal of the study is to facilitate investigation of molecular signaling mechanisms that initiate and mediate the inflammatory response, and eventually to create devices with a more stable neural interface capable of long-term implantation. 
Materials and methods
For this study, unbonded, electrically non-functional, siliconbased probes (University of Michigan Center for Neural Communication Technology, Ann Arbor, Michigan) were utilized. Unbonded devices were fabricated identically to a completely functional device, except for the fact that no connector was attached so no signals were recorded or currents applied through the electrodes. A detailed description of device fabrication methods can be found in Vetter et al [17] . Device dimensions varied in width from 60 to 100 µm at the base (tapering to a point at the end) and 1.7-5.0 mm in length. Some devices were single-shank design while others were multi-shank. All devices were 15 µm thick. To visualize cells near the device two staining methods were employed. One method stains all cell membranes indiscriminately, while the other stains only astrocytes.
Staining method 1
The first staining method used a custom probe with a hole, or 'well,' micromachined near the recording site (as seen in figure 1 ). NeuroTrace R Tissue Labeling Paste (Molecular Probes Inc., Eugene, OR) containing DiI was seeded into the well using previously described micropipetting techniques [15] . DiI, a dialkylcarbocyanine, is a lipophilic fluorescent tracer that labels the plasma membranes of nearby cells. DiI undergoes lateral diffusion through the plasma membrane and is transported both anterograde and retrograde intracellularly. Once the tracer is bound within the membrane, it does not continue to diffuse or undergo transport. By delivering a small, non-renewable amount of dye directly to the site of the electrode, the cells of interest are rapidly labeled for imaging. Once the supply of DiI within the well is exhausted, it does not continue to spread into the tissue to an appreciable extent, and remains at a concentration suitable for visualization.
To initially demonstrate the staining and imaging methods, the device containing DiI was inserted into fixed tissue and processed as follows. Following sacrifice of a Sprague-Dawley rat, the animal was perfusion fixed with 4% paraformaldehyde in physiological saline as per the protocol by Turner et al [10] . The brain was subsequently removed from the skull, and the implant was inserted into the cortical tissue. The entire brain was then soaked in phosphate buffered saline (PBS) for 48 h to allow for diffusion of the dye into the tissue. Following soaking, the region of interest was sectioned on a vibrating microtome (Leica, Deerfield, IL) to capture the implant within a 100-225 µm tissue slice. Confocal microscopy allows a thicker tissue slice to be imaged than would be feasible on standard optical systems, making capture of the electrode within a slice simpler than otherwise possible. The sample was imaged using a Bio-Rad MP confocal microscope with a 40 × 1.3 NA objective. The DiI (excitation: 547 nm/emission: 565 nm) was visualized with a 568 nm krypton laser. The electrode was visualized simultaneously via back-scattered light, or reflectance, imaging techniques with a 488 nm argon laser.
The same techniques were used to visualize the intact tissue-electrode interface of an animal implanted in vivo. The implantation proceeded according to the protocol by Rousche et al [3] . Briefly, the animal was anesthetized using a ketamine-xylazine-acepromazine mixture (100 mg kg −1 ketamine, 20 mg kg −1 xylazine, 10 mg kg −1 acepromazine). The skin and muscle around the implant site was removed and a small craniotomy was made to allow excision of the dura mater and insertion of the electrode. Finally, the craniotomy area was protected with a layer of packed gel-foam and the incision was sutured shut. Four hours after implantation, the animal was sacrificed and perfusion fixed as described above. The brain was immediately removed, sectioned with a vibratome and imaged with a Leica DMIRB fluorescent microscope using a N2.1 filter cube (excitation: BP 515-560 nm/emission: LP 590 nm).
Staining method 2
The second staining method allowed for the imaging of the astrocyte response to device implantation using immunohistochemical-staining techniques in conjunction with confocal microscopy. To show astrocyte distribution in noninjured tissue, an electrode was implanted into brain tissue fixed prior to implantation with the method described earlier.
The neural probe was inserted so its widest portion was in the coronal plane to allow easier capture of the implant within a tissue section. Following implantation, the tissue was sectioned on a vibratome, with the probe contained within a 100-225 µm section. The slice was stained for glial fibrillary acidic protein (GFAP), a cytoskeleton protein expressed in reactive astrocytes. Staining was done according to a protocol modified from Turner et al [10] . Specifically, the tissue samples were first rinsed two times for 30 min in a 5 mg ml −1 solution of sodium borohydride to reduce autofluorescence [18] . Next, the samples were rinsed and soaked overnight in 1% Triton X-100 in Hank's buffer at 4
• C. The tissue was then soaked in a 5% solution of bovine serum albumin (BSA) and 0.2% Triton X-100 for 48 h at 4
• C. Afterwards, the samples were incubated in the primary antibody rabbit anticow glial fibrillary acidic protein (Dako, Carpinteria, CA) for 48 h. After more rinsing, the samples were mounted between two cover slips with Fluoromount-G (Southern Biotechnology Associates, Inc., Birmingham, AL). Imaging of both GFAP and the neural probe was performed using a Leica TCS-SP2 confocal microscope (Leica Microsystems, Bannockburn, IL). GFAP was visualized with a 488 nm argon laser, and the probe was imaged simultaneously using a second photo-multiplier tube and back-scattered light imaging techniques. To demonstrate astrocyte response to an electrode in vivo, a rat was implanted using the surgical procedure outlined previously. After a 1-week survival time, the animal was sacrificed, perfusion fixed and the tissue was sectioned into 100-225 µm sections. The slice was stained for GFAP and imaged following the same procedure described immediately above.
Results
The sectioning and staining techniques presented here were attempted on over 70 devices. The bulk of this study (∼90%) used the immunohistochemical-staining technique (staining method 2) and very long (5 mm) devices that made orienting the device entirely in the plane of the tissue slice relatively difficult. Consequently, capturing the entire device within the tissue slice was only achievable approximately 50% of the time. However in almost all instances, a portion of the probe would remain embedded in a tissue slice after sectioning. When shorter devices (<1 mm) were used, an experienced user could capture the device within the tissue slice over 75% of the time.
Implanting a DiI-loaded well electrode into fixed tissue shows the ability of the probe to deliver fluorophore to the tissue in close proximity to the electrode, eliminating any potential dye penetration issues. This confirms the imaging technique to be an effective method of visualizing an implant within a tissue slice as stained cell membranes and probe features can clearly be seen within a single image (figure 1).
Regarding the in vivo studies, the transport of DiI in living tissue has been found to be 6 mm per day [19, 20] . Thus, stained tissue up to 1 mm from the probe was expected after a 4 h incubation period. Although not shown here, labeled cellular processes could be seen in areas well beyond the tissue-implant interface (>1 mm). More interesting, however, is the specific cellular detail which is discernible immediately adjacent to the probe. As seen in figure 2, cell processes have already begun to attach to the probe surface after just 4 h, forming an intimate connection with the implanted material.
Immunohistochemical The device can be seen as it enters the tissue (upper right), as well as appearing within the tissue, surrounded by cells. The metallic traces reflect more strongly than the silicon substrate, allowing the microstructure of the device to be seen. In this instance, 16 traces distinctly appear running along the shaft of the probe.
The same technique was used to visualize the astrocyte response to a device implanted in vivo for 1 week. Figures 3(C) and (D) show the altered tissue characteristics as a result of the implantation consisting of a high density of GFAP-labeled astrocytes surrounding the probe, in close proximity to the surface.
Discussion
The ability to image the intact tissue-probe interface is an important step in characterizing the inflammatory response to an implanted device. Cellular features in the immediate area of the implant likely play a vital role in the ability of an electrode to function properly over the course of weeks and months [10, 21] , but conventional imaging techniques destroy several cell layers of material in the explantation procedure. Figure 2 demonstrates that within 4 h of implantation, cell end-feet have already began to establish intimate contact with the device. Attachment of cells to the electrode surface is potentially the cause of loss of electrical function in the device, and subsequent removal of the electrode from the tissue would have certainly led to the loss of this information. At this initial stage of the cellular response, no response would likely be detectable at all without visualization of an undisturbed interface.
Despite the potential depth of imaging possible with CLSM and multi-photon confocal laser scanning microscopy (m-CLSM), fluorophore or dye penetration into tissue is often the limiting factor. Delivery of the stain via the implant insures staining of the tissue of interest and allows for visualization of greater depths. Also, the long (24-48 h) incubation times used for the immunohistochemical staining in this study permitted antibody penetration approximately 100-125 µm into the tissue. Therefore, penetration from both sides of the tissue slice allows for complete staining of slices 200-250 µm thick. However, it should be noted that the intensity of staining was more intense on the outer portions of the tissue versus the center. Nevertheless, the staining within the small regions of interest that were imaged (usually only tens of micrometers thick) was uniform enough so that staining inconsistencies were not an issue.
The other staining method depicts a large number of cellular processes near the device (figure 1). However, the distance that these features extend from the device is limited. This was due to the short time frame of the experiment and a limited amount of dye starting from a concentrated location. Nevertheless, these results were consistent with previous studies showing the diffusion rate of lipophilic tracers such as DiI to be approximately 0.2-0.6 mm per day in fixed tissue [20, 22] .
By simultaneously imaging the probe as well as the surrounding tissue, it is possible to investigate localized features surrounding individual electrode sites. In the past, confocal image reconstruction and tract tracing were used to try to localize the tissue where individual electrodes previously resided [10, 15, 16] . However, since these techniques are used in tissue where the device has been removed prior to imaging, fine detail regarding the interface is not attainable. In figure 1 , the individual electrode sites can be clearly seen within the surrounding neural tissue. This may become important when attempting to determine which cell's signal is being recorded, the mode of failure for individual electrode sites or correlating signal attenuation with surrounding tissue characteristics.
Preliminary, qualitative observations of the samples also show gliotic inflammatory responses extending tens to hundreds of micrometers from the device. This is consistent with others findings where GFAP-labeled cells were found at distances up to 600 µm from the device [10] . Furthermore, figure 3 demonstrates the difference in morphology between cells (astrocytes) that were fixed and stained prior to implantation and those done post-implantation. GFAP-labeled astrocytes are shown with a consistent stellate morphology in their native, undisturbed state in figures 3(A) and (B). However, figures 3(C) and (D) clearly depict a morphology change as astrocytes can be seen enveloping the implant. Additionally, the intensity of the GFAP staining and astrocyte distribution is noticeably higher in the area immediately adjacent to the implant.
Silicon as the device material has a number of advantages that make it attractive for intact tissue-electrode interface imaging.
First, it is a common material in microelectromechanical systems (MEMS) processing techniques, which are often used to fabricate microelectrodes. Second, unlike other materials such as polyimide, silicon does not autofluoresce at the wavelengths commonly used in cellular imaging. This allows cells near the probe to be clearly seen, and does not wash out the image with an abundance of signal. The high reflectance of silicon means backscattered light imaging techniques can be used to determine the exact location of the probe while simultaneously imaging the surrounding tissue. Although still a time-consuming and imperfect process, sectioning of tissue around the implant is made much easier since thick slices of 200 µm or more can be used with these imaging techniques. Additionally, the use of mutli-photon confocal laser scanning microscopy (m-CLSM) in conjunction with stains delivered via the device would allow for even thicker slices to be used as the difficulties with stain penetration and imaging extremely thick tissue sections (>500 µm) could be circumvented.
Conclusions
Visualization of the intact tissue-implant interface is an important aspect of characterizing the inflammatory response to a foreign body. In the case of neural prosthetic devices, this reaction is critical to the continuing ability of the probe to act as an electrical interface with nervous tissue. However, it can be difficult to capture an implant within a standard tissue slice for imaging purposes, and it is impossible to avoid destruction of the interface when removing the electrode from the tissue.
Confocal and fluorescent microscopy techniques are presented that allow significantly thicker slices to be used, making it easier to capture the probe within a tissue section without disturbing the interface. These methods also allow simultaneous visualization of the probe and its surrounding tissue, and are amenable to a variety of tissue-staining techniques. Used in conjunction with other analysis techniques, the methods presented here will assist in the development and evaluation of more effective neural prosthetics.
